Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Xu, Bo ^a   Li, Kun Ping ^a   Shen, Fei ^a   Xiao, Huan Qing ^a   Cai, Wen Song ^a   Li, Jiang Lin ^a   Liu, Qi Cai ^b   Jia, Lin ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; PLASMIN; ULINASTATIN; GLYCOPROTEIN; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBRINOLYTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; CANCER CELL CULTURE; CANCER RECURRENCE; CELL ASSAY; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GELATIN ZYMOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LIVER RESECTION; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; STEREOLOGY; TRANSWELL CELL INVASION ASSAY; TUMOR INVASION; ZYMOGRAPHY; ANIMAL; COLONIC NEOPLASMS; HCT116 CELL LINE; HUMAN; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; SECONDARY; CELL STRAIN HCT116; COLON TUMOR; LIVER TUMOR; METASTASIS; TUMOR RECURRENCE;

ANIMALS; COLONIC NEOPLASMS; GLYCOPROTEINS; HCT116 CELLS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; NEOPLASM RECURRENCE, LOCAL;

EID: 84878145097     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/437950     Document Type: Article

References (47)

1. Hughes K. S., Simon R., Songhorabodi S., Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986 100 2 278 284 2-s2.0-0022469425 (Pubitemid 16070861)
2. Jarnagin W. R., Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Annals of Surgical Oncology 2010 17 5 1226 1233 2-s2.0-77952081222 10.1245/s10434-010-0978-3
3. Xu J., Wei Y., Zhong Y., Fan J., Zhou J., Qin L., Ren L., Qin X., Hepatectomy for liver metastasis of colorectal cancer. International Journal of Colorectal Disease 2009 24 4 419 425 2-s2.0-61549111273 10.1007/s00384-008-0619- 5
4. Talvinen K., Tuikkala J., Grönroos J., Huhtinen H., Kronqvist P., Aittokallio T., Nevalainen O., Hiekkanen H., Nevalainen T., Sundström J., Biochemical and clinical approaches in evaluating the prognosis of colon cancer. Anticancer Research 2006 26 6C 4745 4751 2-s2.0-33845920743 (Pubitemid 46032107)
5. Chua Y. J., Cunningham D., Neoadjuvant treatment of unresectable liver metastases from colorectal cancer. Clinical Colorectal Cancer 2006 5 6 405 412 2-s2.0-33646140324 10.3816/CCC.2006.n.011
6. Asaga T., Suzuki K., Umeda M., Sugimasa Y., Takemiya S., Okamoto T., The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Japanese Journal of Surgery 1991 21 6 669 675 2-s2.0-0026328927
7. Gutman M., Singh R. K., Price J. E., Fan D., Fidler I. J., Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Invasion and Metastasis 1994 14 1-6 362 371 2-s2.0-0028674678
8. Mizutani J., Hiraoka T., Yamashita R., Miyauchi Y., Promotion of hepatic metastases by liver resection in the rat. British Journal of Cancer 1992 65 6 794 797 2-s2.0-0026651807
9. Harun N., Nikfarjam M., Muralidharan V., Christophi C., Liver regeneration stimulates tumor metastases. Journal of Surgical Research 2007 138 2 284 290 2-s2.0-33847626006 10.1016/j.jss.2006.06.024 (Pubitemid 46365721)
10. Xu B., Cai W. S., Xiao H. Q., Li S. H., Xia J. T., Zhu G. H., Weng J. F., Influence of liver regeneration after partial hepatectomy on the development of liver metastasis of colon cancer in rats. Zhonghua Wai Ke Za Zhi 2009 47 5 369 372 2-s2.0-77955494389
11. Leeman M. F., Curran S., Murray G. I., New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. Journal of Pathology 2003 201 4 528 534 2-s2.0-1342333566 10.1002/path.1466 (Pubitemid 38256401)
12. Matsuyama Y., Takao S., Aikou T., Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. Journal of Surgical Oncology 2002 80 2 105 110 2-s2.0-0036267895 10.1002/jso.10106 (Pubitemid 34569178)
13. Zucker S., A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumor surface proteinases. Cancer Investigation 1988 6 2 219 231 2-s2.0-0023911617
14. Zucker S., Cao J., Chen W. T., Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000 19 56 6642 6650 2-s2.0-0034722898 10.1038/sj.onc.1204097 (Pubitemid 32197703)
15. Dormn G., Cseh S., Hajd I., Barna L., Knya D., Kupai K., Kovcs L., Ferdinandy P., Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility. Drugs 2010 70 8 949 964 2-s2.0-77952647070 10.2165/11318390-000000000-00000
16. Mignatti P., Rifkin D. B., Biology and biochemistry of proteinases in tumor invasion. Physiological Reviews 1993 73 1 161 195 2-s2.0-0027535914 (Pubitemid 23065437)
17. Hogan N. M., Dwyer R. M., Joyce M. R., Kerin M. J., Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. International Journal of Cancer 2012 131 1 1 7 10.1002/ijc.27458
18. Pugia M. J., Lott J. A., Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clinical Chemistry and Laboratory Medicine 2005 43 1 1 16 2-s2.0-14244260288 10.1515/CCLM.2005.001 (Pubitemid 40287494)
19. Kobayashi H., Suzuki M., Tanaka Y., Kanayama N., Terao T., A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor- β 1 signaling cascade. Journal of Biological Chemistry 2003 278 10 7790 7799 2-s2.0-0037424469 10.1074/jbc.M210407200 (Pubitemid 36800512)
20. Kobayashi H., Yagyu T., Inagaki K., Kondo T., Suzuki M., Kanayama N., Terao T., Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer. Cancer 2004 100 4 869 877 2-s2.0-0842347566 10.1002/cncr.20034 (Pubitemid 38176868)
21. Suzuki M., Kobayashi H., Tanaka Y., Hirashima Y., Kanayama N., Takei Y., Saga Y., Suzuki M., Itoh H., Terao T., Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. International Journal of Cancer 2003 104 3 289 302 2-s2.0-0037431429 10.1002/ijc.10950 (Pubitemid 36249811)
22. Yoshioka I., Tsuchiya Y., Aozuka Y., Onishi Y., Sakurai H., Koizumi K., Tsukada K., Saiki I., Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells. Anticancer Research 2005 25 2A 815 820 2-s2.0-17444430411 (Pubitemid 40546848)
23. Tsui K. H., Chang P. L., Feng T. H., Chung L. C., Hsu S. Y., Juang H. H., Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Research 2008 28 4A 1977 1983 2-s2.0-48549085959
24. Nikfarjam M., Muralidharan V., Christophi C., Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 2006 139 1 73 81 2-s2.0-29144473021 10.1016/j.surg.2005.07.030 (Pubitemid 41814435)
25. Shimizu M., Saitoh Y., Itoh H., Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Human Pathology 1990 21 6 607 612 2-s2.0-0025344972 10.1016/S0046-8177(96)90006- 4 (Pubitemid 20204948)
26. Collins F. S., Reengineering translational science: the time is right. Science Translational Medicine 2011 3 90 90cm17 10.1126/scitranslmed.3002747
27. Tsujino T., Komatsu Y., Isayama H., Hirano K., Sasahira N., Yamamoto N., Toda N., Ito Y., Nakai Y., Tada M., Matsumura M., Yoshida H., Kawabe T., Shiratori Y., Omata M., Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clinical Gastroenterology and Hepatology 2005 3 4 376 383 2-s2.0-20144387532 10.1016/S1542-3565(04)00671-8 (Pubitemid 40488346)
28. Hoogerwerf W. A., Pharmacological management of pancreatitis. Current Opinion in Pharmacology 2005 5 6 578 582 2-s2.0-27744496912 10.1016/j.coph.2005. 06.007 (Pubitemid 41614455)
29. Aihara T., Shiraishi M., Hiroyasu S., Hatsuse K., Mochizuki H., Seki S., Hiraide H., Muto Y., Ulinastatin, a protease inhibitor, attenuates hepatic ischemia/reperfusion injury by downregulating TNF- α in the liver. Transplantation Proceedings 1998 30 7 3732 3734 2-s2.0-0032210412 (Pubitemid 128712814)
30. Nakahama H., Obata K., Sugita M., Ulinastatin ameliorates acute ischemic renal injury in rats. Renal Failure 1996 18 6 893 898 2-s2.0-0029967903 (Pubitemid 26399127)
31. Cao Z. L., Okazaki Y., Naito K., Ueno T., Natsuaki M., Itoh T., Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. Annals of Thoracic Surgery 2000 69 4 1121 1126 2-s2.0-0034017155 10.1016/S0003-4975(99)01433-2 (Pubitemid 30259371)
32. Binns O. A. R., DeLima N. F., Buchanan S. A., Mauney M. C., Cope J. T., Thies S. D., Shockey K. S., Tribble C. G., Kron I. L., Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation. Journal of Thoracic and Cardiovascular Surgery 1996 112 3 607 613 2-s2.0-0029859285 10.1016/S0022-5223(96)70042-9 (Pubitemid 26347013)
33. Okuhama Y., Shiraishi M., Higa T., Tomori H., Taira K., Mamadi T., Muto Y., Protective effects of ulinastatin against ischemia-reperfusion injury. Journal of Surgical Research 1999 82 1 34 42 2-s2.0-0032839609 10.1006/jsre.1998.5496 (Pubitemid 29394150)
34. Nakanishi K., Takeda S., Sakamoto A., Kitamura A., Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction. Critical Care Medicine 2006 34 5 1351 1357 2-s2.0-33646591214 10.1097/01.CCM.0000215110.55899.AE
35. Nishiyama T., Yokoyama T., Yamashita K., Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery. Journal of Anesthesia 2006 20 3 179 182 2-s2.0-33746897697 10.1007/s00540-006-0396-7 (Pubitemid 44193524)
36. Kurosawa S., Kanaya N., Fujimura N., Nakayama M., Edanaga M., Mizuno E., Park K. W., Namiki A., Effects of ulinastatin on pulmonary artery pressure during abdominal aortic aneurysmectomy. Journal of Clinical Anesthesia 2006 18 1 18 23 2-s2.0-33644698365 10.1016/j.jclinane.2005.05.008 (Pubitemid 43330763)
37. Yano T., Anraku S., Nakayama R., Ushijima K., Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003 98 2 465 473 2-s2.0-0037315686 10.1097/00000542- 200302000-00028 (Pubitemid 36592816)
38. Kobayashi H., Suzuki M., Kanayama N., Nishida T., Takigawa M., Terao T., Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade. European Journal of Biochemistry 2002 269 16 3945 3957 2-s2.0-0036039046 10.1046/j.1432-1033.2002.03068.x (Pubitemid 34994889)
39. Masson S., Daveau M., Hiron M., Lyoumi S., Lebreton J. P., Ténière P., Scotté M., Differential regenerative response and expression of growth factors following hepatectomy of variable extent in rats. Liver 1999 19 4 312 317 2-s2.0-0032794248 10.1111/j.1478-3231.1999. tb00055.x (Pubitemid 29359096)
40. Jiang W., Hiscox S., Matsumoto K., Nakamura T., Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Critical Reviews in Oncology/Hematology 1999 29 3 209 248 2-s2.0-0032946931 10.1016/S1040-8428(98)00019-5 (Pubitemid 29158969)
41. Lukomska B., Dluzniewska J., Polanski J., Zajac L., Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comparative Hepatology 2004 3 supplement 1 S52 10.1186/1476-5926-2-S1-S52
42. Yoon S. S., Kim S. H., Gonen M., Heffernan N. M., Detwiller K. Y., Jarnagin W. R., D'Angelica M., Blumgart L. H., Tanabe K. K., DeMatteo R. P., Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Annals of Surgical Oncology 2006 13 3 353 362 2-s2.0-32844462558 10.1245/ASO.2006.03.060
43. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., Mignatti P., Control of type IV collagenase activity by the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. The EMBO Journal 1997 16 9 2319 2332 2-s2.0-0030977009 10.1093/emboj/16.9.2319 (Pubitemid 27258633)
44. Inuzuka K., Ogata Y., Nagase H., Shirouzu K., Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. Journal of Surgical Research 2000 93 2 211 218 2-s2.0-0033779222 10.1006/jsre.2000.5952
45. Mekkawy A. H., Morris D. L., Pourgholami M. H., Urokinase plasminogen activator system as a potential target for cancer therapy. Future Oncology 2009 5 9 1487 1499 2-s2.0-74949099621 10.2217/fon.09.108
46. Sternlicht M. D., Werb Z., How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 2001 17 463 516 2-s2.0-0035188727 10.1146/annurev.cellbio.17.1.463 (Pubitemid 33096184)
47. Nobuoka T., Mizuguchi T., Oshima H., Shibata T., Kaji S., Nagayama M., Meguro M., Mitaka T., Hirata K., Impaired liver regeneration with humoral and genetic disturbances in urinary trypsin inhibitor-deficient mice. Liver International 2009 29 7 979 987 2-s2.0-67650504279 10.1111/j.1478-3231.2009. 01990.x